Murray J, Gregory W F, Gomez-Escobar N, Atmadja A K, Maizels R M
Ashworth Laboratories, Institute of Cell, Animal and Population Biology, University of Edinburgh, West Mains Road, EH9 3JT, Edinburgh, UK.
Mol Biochem Parasitol. 2001 Nov;118(1):89-96. doi: 10.1016/s0166-6851(01)00374-7.
Several important nematode parasites have been found to express members of a gene family variously termed as venom allergen antigen homologue (vah) or Ancylostoma secreted protein (asp). In some cases these products are secreted by infective larval stages and have been suggested to be effective vaccine immunogens. We isolated the corresponding gene from the human filarial nematode, Brugia malayi, by first searching the expressed sequence tag (EST) dataset generated by the Filarial Genome Project and then using gene-specific nondegenerate primers matching the selected gene for PCR, from B. malayi cDNA libraries. We report here the full-length gene sequence, which we have designated as Bm-val-1, for vah/asp-like. The corresponding protein (Bm-VAL-1) contains 232 amino acids in a single homology unit, unlike products from some other species in which there is a tandem repeat. A putative signal sequence is present at the 5' end and there are two potential N-glycosylation sites. Murine antibodies to recombinant Bm-VAL-1 react with a 28 kDa protein in L3 extracts and recombinant Bm-VAL-1 is recognised by murine T cells primed with soluble L3 proteins. Of 82 ESTs corresponding to Bm-val-1, 72 are recorded from the infective larval (L3) stage. However, PCR on the first-strand cDNA from later mammalian stages revealed some expression at most subsequent time points. Over 95% (20/21) of microfilaraemic human filariasis patients are seropositive for antibodies to Bm-VAL-1, with particularly high levels of IgG3 and IgG4 isotypes. The IgG4 subclass may indicate stimulation by adult and/or microfilarial-derived immunogens. The association of Bm-VAL-1 with the infective stage and its recognition by humans exposed to filariasis suggests that further evaluation of this antigen as a vaccine candidate should be performed.
已发现几种重要的线虫寄生虫可表达一个基因家族的成员,该基因家族有多种命名,如毒液变应原抗原同源物(vah)或钩虫分泌蛋白(asp)。在某些情况下,这些产物由感染性幼虫阶段分泌,并被认为是有效的疫苗免疫原。我们从人类丝虫线虫马来布鲁线虫中分离出相应基因,首先搜索丝虫基因组计划生成的表达序列标签(EST)数据集,然后使用与所选基因匹配的基因特异性简并引物,从马来布鲁线虫cDNA文库中进行PCR扩增。我们在此报告全长基因序列,我们将其命名为Bm-val-1,属于vah/asp样基因。相应的蛋白质(Bm-VAL-1)在单个同源单位中含有232个氨基酸,这与其他一些物种的产物不同,后者存在串联重复。在5'端存在一个推定的信号序列,并且有两个潜在的N-糖基化位点。针对重组Bm-VAL-1的鼠抗体与L3提取物中的一种28 kDa蛋白质发生反应,并且重组Bm-VAL-1被用可溶性L3蛋白质致敏的鼠T细胞识别。在与Bm-val-1对应的82个EST中,72个记录于感染性幼虫(L3)阶段。然而,对来自后期哺乳动物阶段的第一链cDNA进行PCR显示,在大多数后续时间点有一些表达。超过95%(20/21)的微丝蚴血症人类丝虫病患者对Bm-VAL-1抗体呈血清阳性,尤其是IgG3和IgG4同种型水平较高。IgG4亚类可能表明受到成虫和/或微丝蚴来源的免疫原的刺激。Bm-VAL-1与感染阶段的关联及其被接触丝虫病的人类识别,表明应进一步评估该抗原作为候选疫苗的可能性。